Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.
- 1 June 1996
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 97 (11) , 2452-2468
- https://doi.org/10.1172/jci118692
Abstract
We have related experimentally induced post-cardiac transplant coronary arteriopathy to increased elastolytic activity, IL-1beta, fibronectin-mediated inflammatory and smooth muscle cell (SMC) migration, and SMC proliferation. Since our in vitro studies show that a serine elastase releases SMC mitogens and facilitates IL-lbeta induction of fibronectin, we hypothesized that administration in vivo of the specific serine elastase inhibitor, elafin, would decrease the post-cardiac transplant coronary arteriopathy. Cholesterol-fed rabbits underwent a heterotopic cardiac transplant without immunosuppression and received elafin (1.79 mg/kg per d continuous infusion after a 9 mg bolus, n = 6) or vehicle (n = 6). 1 wk later, hearts were harvested for morphometric, immunohistochemical, and biochemical analyses. A > 70% decrease in the total number of coronary arteries with intimal thickening in elafin-treated compared to control donor hearts (P < 0.002) was associated with reduced vascular elastolytic activity judged by fewer breaks in the internal elastic lamina (P < 0.03), less accumulation of immunoreactive fibronectin (P < 0.02), and reduced cell proliferation quantified by proliferating cell nuclear antigen (P < 0.0001). Despite myocardial lymphocytic infiltration, wet weight of elafin-treated donor hearts was reduced by 50% compared to untreated controls (P < 0.002) and associated with relative preservation of myocyte integrity, instead of extensive myocardial necrosis (P < 0.004). This protective effect correlated with decreased myocardial elastolytic activity (P < 0.0001) and inflammatory cell proliferation (P < 0.0001) and with an elafin-inhibitable elastase in lymphocytes. Serine elastase activity thus appears an important therapeutic target for post-cardiac transplant coronary arteriopathy and myocardial necrosis induced by rejection.Keywords
This publication has 98 references indexed in Scilit:
- The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin.Journal of Clinical Investigation, 1994
- Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets.Journal of Clinical Investigation, 1993
- Myocardial matrix metalloproteinase(s): localization and activationMolecular and Cellular Biochemistry, 1993
- Proteases and lymphocyte cytotoxic killing mechanismsCurrent Opinion in Immunology, 1993
- Potential role of two novel elastase-like enzymes in processing pro-transforming growth factor-.alpha.Biochemistry, 1993
- Synthesis and structure-activity relationships of elafin, an elastase-specific inhibitorBiochemical and Biophysical Research Communications, 1992
- A study of elastic tissue and actinic radiation in “aging,” temporal arteritis, polymyalgia rheumatica, and atherosclerosis: The actinic storm in the modern worldJournal of the American Academy of Dermatology, 1991
- Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migrationDevelopmental Biology, 1991
- Elafin is a potent inhibitor of proteinase 3Biochemical and Biophysical Research Communications, 1991
- Isolation, purification and properties of aortic elastaseFEBS Letters, 1975